Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle R Lofwall

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
Experimental and Clinical Psychopharmacology|November 14, 2024
Residual next-day effects of alprazolam on psychomotor performance and simulated driving in healthy normal adultsStevie C Roszkowski, Shanna Babalonis, Marion A Coe, et al.
Journal of Viral Hepatitis|March 4, 2024
Predictors of engagement in screening for a hepatitis C virus (HCV) treatment trial in a rural Appalachian communityJennifer R Havens, Michelle R Lofwall, April M Young, et al.
Drug and Alcohol Dependence|December 4, 2012
Atomoxetine does not alter cocaine use in cocaine dependent individuals: double blind randomized trialSharon L Walsh, Lisa S Middleton, Conrad J Wong, et al.
Journal of Substance Use and Addiction Treatment|May 19, 2026
Organizational perspectives on barriers and facilitators to an integrated care model for opioid use disorder and serious injection-related infectionsHilary L Surratt, Michelle R Lofwall, Elizabeth O Nelson, et al.
Substance Abuse Treatment, Prevention, and Policy|June 27, 2026
Staff perceptions of care navigators in medication for opioid use disorder treatment settingsMichael Goetz, Shaquita Andrews-Higgins, Olivia A Davis, et al.
Psychopharmacology|November 10, 2020
Acute administration of oxycodone, alcohol, and their combination on simulated driving-preliminary outcomes in healthy adultsShanna Babalonis, Marion A Coe, Paul A Nuzzo, et al.
Inflammatory Bowel Diseases|April 4, 2017
Predictors of Chronic Opioid Use in Newly Diagnosed Crohn's DiseaseNathan J Pauly, Lamprinos Michailidis, Michael G Kindred, et al.
JAMA Network Open|June 25, 2024
Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder With Fentanyl Use: A Post Hoc Analysis of a Randomized Clinical TrialEdward V Nunes, Sandra D Comer, Michelle R Lofwall, et al.
Journal of Substance Use and Addiction Treatment|October 22, 2025
Impact of a brief personally tailored opioid-overdose and medication for opioid use disorder education intervention on naloxone acceptance in peripartum individuals: A secondary exploratory analysisMichelle R Lofwall, Frankie Kropp, Jasmin Charles, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|February 7, 2026
Clinical and demographic characteristics of participants in a hepatitis C treatment trial in rural Kentucky: How policies around treatment access may impact elimination efforts in the United StatesJennifer R Havens, Brittney D Williams, Takako Schaninger, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Experimental and Clinical Psychopharmacology|November 14, 2024
Residual next-day effects of alprazolam on psychomotor performance and simulated driving in healthy normal adultsStevie C Roszkowski, Shanna Babalonis, Marion A Coe, et al.
Journal of Viral Hepatitis|March 4, 2024
Predictors of engagement in screening for a hepatitis C virus (HCV) treatment trial in a rural Appalachian communityJennifer R Havens, Michelle R Lofwall, April M Young, et al.
Drug and Alcohol Dependence|December 4, 2012
Atomoxetine does not alter cocaine use in cocaine dependent individuals: double blind randomized trialSharon L Walsh, Lisa S Middleton, Conrad J Wong, et al.
Journal of Substance Use and Addiction Treatment|May 19, 2026
Organizational perspectives on barriers and facilitators to an integrated care model for opioid use disorder and serious injection-related infectionsHilary L Surratt, Michelle R Lofwall, Elizabeth O Nelson, et al.
Substance Abuse Treatment, Prevention, and Policy|June 27, 2026
Staff perceptions of care navigators in medication for opioid use disorder treatment settingsMichael Goetz, Shaquita Andrews-Higgins, Olivia A Davis, et al.
Psychopharmacology|November 10, 2020
Acute administration of oxycodone, alcohol, and their combination on simulated driving-preliminary outcomes in healthy adultsShanna Babalonis, Marion A Coe, Paul A Nuzzo, et al.
Inflammatory Bowel Diseases|April 4, 2017
Predictors of Chronic Opioid Use in Newly Diagnosed Crohn's DiseaseNathan J Pauly, Lamprinos Michailidis, Michael G Kindred, et al.
JAMA Network Open|June 25, 2024
Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder With Fentanyl Use: A Post Hoc Analysis of a Randomized Clinical TrialEdward V Nunes, Sandra D Comer, Michelle R Lofwall, et al.
Journal of Substance Use and Addiction Treatment|October 22, 2025
Impact of a brief personally tailored opioid-overdose and medication for opioid use disorder education intervention on naloxone acceptance in peripartum individuals: A secondary exploratory analysisMichelle R Lofwall, Frankie Kropp, Jasmin Charles, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|February 7, 2026
Clinical and demographic characteristics of participants in a hepatitis C treatment trial in rural Kentucky: How policies around treatment access may impact elimination efforts in the United StatesJennifer R Havens, Brittney D Williams, Takako Schaninger, et al.
Pageof 13